Displaying 1 to 6 of 6 investments
Country Date Notes
BiPar Sciences Inc
Biopharmaceutical company developing and commercializing tumor-selective drugs for cancer patients.
United States 1 Dec 2004 Series A
Active
BiPar Sciences Inc
Biopharmaceutical company developing and commercializing tumor-selective drugs for cancer patients.
United States 1 Feb 2007 Series B
Active
BiPar Sciences Inc
Biopharmaceutical company developing and commercializing tumor-selective drugs for cancer patients.
United States 1 Jan 2009 Series C
Active
Corium International Inc
United States 1 Sep 2007 Series C
Active
Magnolia Broadband
Fabless semiconductor company building Antenna Diversity solutions for the wireless handsets.
United States 1 Jan 2006 Series D
Vaxart Inc
Vaxart is a vaccine development company.
United States 1 Jan 2010 Series B